000 | 01890 a2200529 4500 | ||
---|---|---|---|
005 | 20250517141902.0 | ||
264 | 0 | _c20171031 | |
008 | 201710s 0 0 eng d | ||
022 | _a1098-660X | ||
024 | 7 |
_a10.1128/JCM.02319-16 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTruong, Cynthia Y | |
245 | 0 | 0 |
_aReal-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates. _h[electronic resource] |
260 |
_bJournal of clinical microbiology _c05 2017 |
||
300 |
_a1276-1284 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aClostridioides difficile _xdrug effects |
650 | 0 | 4 |
_aCross Infection _xepidemiology |
650 | 0 | 4 |
_aDiarrhea _xdiagnosis |
650 | 0 | 4 |
_aElectronic Data Processing _xmethods |
650 | 0 | 4 |
_aEnterocolitis, Pseudomembranous _xdiagnosis |
650 | 0 | 4 |
_aEvidence-Based Medicine _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospital Information Systems |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLaxatives _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetronidazole _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
700 | 1 | _aGombar, Saurabh | |
700 | 1 | _aWilson, Richard | |
700 | 1 | _aSundararajan, Gopalakrishnan | |
700 | 1 | _aTekic, Natasa | |
700 | 1 | _aHolubar, Marisa | |
700 | 1 | _aShepard, John | |
700 | 1 | _aMadison, Alexandra | |
700 | 1 | _aTompkins, Lucy | |
700 | 1 | _aShah, Neil | |
700 | 1 | _aDeresinski, Stan | |
700 | 1 | _aSchroeder, Lee F | |
700 | 1 | _aBanaei, Niaz | |
773 | 0 |
_tJournal of clinical microbiology _gvol. 55 _gno. 5 _gp. 1276-1284 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.02319-16 _zAvailable from publisher's website |
999 |
_c26926145 _d26926145 |